Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04169841
Title	Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment (GUIDE2REPAIR)
Acronym	GUIDE2REPAIR
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Centre Georges Francois Leclerc
Indications	endometrial cancer clear cell renal cell carcinoma ovarian cancer lung cancer breast cancer prostate cancer head and neck cancer transitional cell carcinoma
Therapies	Durvalumab + Olaparib + Tremelimumab
Age Groups:	adult \| senior
Covered Countries	FRA